Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
Edward J. Benz, Jr., MD, president of Dana-Farber; Ambassador
Nancy G. Brinker, founding chair of Susan G. Komen for the Cure; and
Eric Winer, MD, director of the Breast Oncology Center at Dana-Farber
Ambassador Nancy G. Brinker, founding chair of Susan G. Komen for the
Cure®, the world's largest grassroots network of breast cancer
survivors and activists, presented the keynote address at Dana-Farber
Cancer Institute's Aesclepian Society dinner on Thursday, May 7.
"Society looks to science and medicine to alleviate suffering. And
science looks to society for the funding and public support that make
discoveries possible. Dana-Farber's presence here reminds us that no
disease is cured in a laboratory alone," said Brinker, adding,
"Dana-Farber has been on the cutting-edge of breast cancer for as long
as I've been in this field."
The dinner, held at the Four Seasons Hotel Boston, recognized
Dana-Farber and Jimmy Fund supporters who have made one-time commitments
of $1 million or more.
"We are very grateful for the support we have received over the years
from Susan G. Komen for the Cure," said Susan S. Paresky, senior vice
president for Development at Dana-Farber. "Their most recent gift this
year is enabling Dana-Farber physician-scientists to accelerate the
study of treatment disparities in breast cancer and expanded clinical
trials of promising pre-operative therapies."